Free Trial

Northern Trust Corp Boosts Stake in First Advantage Co. (NYSE:FA)

First Advantage logo with Business Services background

Northern Trust Corp raised its stake in First Advantage Co. (NYSE:FA - Free Report) by 32.8% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 565,327 shares of the company's stock after buying an additional 139,536 shares during the period. Northern Trust Corp owned about 0.33% of First Advantage worth $10,589,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also recently made changes to their positions in FA. Summit Investment Advisors Inc. increased its stake in First Advantage by 15.3% in the fourth quarter. Summit Investment Advisors Inc. now owns 6,267 shares of the company's stock valued at $117,000 after acquiring an additional 832 shares during the last quarter. Advisory Research Inc. boosted its holdings in shares of First Advantage by 0.6% in the 4th quarter. Advisory Research Inc. now owns 212,446 shares of the company's stock worth $3,979,000 after purchasing an additional 1,216 shares in the last quarter. Corebridge Financial Inc. grew its position in First Advantage by 9.6% during the fourth quarter. Corebridge Financial Inc. now owns 29,784 shares of the company's stock valued at $558,000 after acquiring an additional 2,607 shares during the last quarter. Oppenheimer Asset Management Inc. grew its holdings in shares of First Advantage by 17.6% during the 4th quarter. Oppenheimer Asset Management Inc. now owns 19,626 shares of the company's stock valued at $368,000 after purchasing an additional 2,938 shares during the last quarter. Finally, Alliancebernstein L.P. raised its position in First Advantage by 7.2% in the 4th quarter. Alliancebernstein L.P. now owns 59,600 shares of the company's stock worth $1,116,000 after purchasing an additional 4,000 shares during the period. Hedge funds and other institutional investors own 94.91% of the company's stock.

Wall Street Analysts Forecast Growth

Several analysts have issued reports on the stock. William Blair restated an "outperform" rating on shares of First Advantage in a research report on Friday, February 28th. BMO Capital Markets dropped their target price on First Advantage from $24.00 to $22.00 and set an "outperform" rating for the company in a report on Monday, March 3rd. Royal Bank of Canada lowered First Advantage from an "outperform" rating to a "sector perform" rating and set a $20.00 price target on the stock. in a research report on Friday, May 9th. Finally, Barclays reiterated an "equal weight" rating and issued a $15.00 price objective (down previously from $20.00) on shares of First Advantage in a research report on Thursday, April 10th. Five equities research analysts have rated the stock with a hold rating and three have given a buy rating to the stock. According to MarketBeat, the stock has a consensus rating of "Hold" and a consensus price target of $65.40.

Get Our Latest Research Report on First Advantage

First Advantage Trading Down 4.8%

FA traded down $0.87 during midday trading on Wednesday, reaching $17.30. 1,153,314 shares of the company's stock traded hands, compared to its average volume of 824,304. First Advantage Co. has a 52 week low of $12.32 and a 52 week high of $20.79. The company has a debt-to-equity ratio of 0.61, a current ratio of 3.85 and a quick ratio of 3.85. The firm has a fifty day moving average of $14.75 and a two-hundred day moving average of $16.99. The stock has a market capitalization of $3.00 billion, a price-to-earnings ratio of 576.67 and a beta of 1.20.

First Advantage (NYSE:FA - Get Free Report) last posted its earnings results on Thursday, May 8th. The company reported $0.17 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.13 by $0.04. First Advantage had a return on equity of 13.16% and a net margin of 0.65%. During the same quarter in the previous year, the firm earned $0.17 EPS. The firm's revenue was up 109.3% compared to the same quarter last year. On average, equities analysts anticipate that First Advantage Co. will post 0.74 earnings per share for the current fiscal year.

First Advantage Company Profile

(Free Report)

First Advantage Corporation provides employment background screening, identity, and verification solutions worldwide. It offers pre-onboarding products and solutions, such as criminal background checks, drug/health screening, extended workforce screening, FBI channeling, identity checks and biometric fraud mitigation tools, education/work history verification, driver records and compliance, healthcare credentials, executive screening, and other screening products.

Featured Stories

Institutional Ownership by Quarter for First Advantage (NYSE:FA)

Should You Invest $1,000 in First Advantage Right Now?

Before you consider First Advantage, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and First Advantage wasn't on the list.

While First Advantage currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

 The Best Nuclear Energy Stocks to Buy Cover

Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

This $13 Trillion Energy Breakthrough Will Make Millionaires
Magnificent 7 Stocks Shift Toward Stability and Selective Growth
4 Biotech Stocks on the Verge of Massive Breakthroughs

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines